Technology

Unlocking Endogenous Bioactive Lipids to Treat IBD

Our proprietary platform technology transforms endogenous bioactive lipids with immuno-resolving properties into new molecular entities to overcome the formulation and IP hurdles that have limited their development as pharmaceutical drugs.


 

 

Proven Lipid Biology
 

+

 

HEALER™ Platform
 

+

 

Intellectual Property
 

=

 

New Therapies